Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3652 MAD Study in Healthy Subjects
NCT02243657Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- May 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of asp3652 in chronic pelvic pain (CPP) and interstitial cystitis (IC) (6 arms), sponsored by Astellas Pharma. Primary endpoints: Nature, frequency and severity of adverse events, Physical examination and vital signs and 29 more. Started May 2009; status: completed.
02
Drugs
asp3652
03
Conditions
chronic pelvic pain (CPP)interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT02243657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243657.